A Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Combinations of Monoclonal Antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS Administered Via Intravenous Infusion in Healthy, HIV-uninfected Adult Participants
Phase of Trial: Phase I
Latest Information Update: 21 Aug 2019
Price : $35 *
At a glance
- Drugs 10 1074 (Primary) ; PGDM1400 (Primary) ; PGT 121 (Primary) ; VRC 01LS (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacodynamics
- Acronyms CAP 012A
- 26 Jul 2019 Status changed from not yet recruiting to recruiting.
- 10 Jul 2019 Planned initiation date changed from 1 Jun 2019 to 1 Aug 2019.
- 14 Nov 2018 New trial record